TORONTO--(BUSINESS WIRE)--FUJIFILM VisualSonics Inc., a world leader in ultra high frequency ultrasound and photoacoustic imaging systems and subsidiary of FUJIFILM SonoSite, Inc., today announced the launch of its new Vevo LAZR-X, the world’s only customizable imaging platform combining ultra high frequency ultrasound and photoacoustics for animal research applications. Featuring superior image resolution—down to 30 microns—the Vevo LAZR-X was designed for a variety of translational research applications including oncology, molecular biology, cardiology and neurobiology.

“Fujifilm VisualSonics is proud to debut another industry-first and a powerful innovation for today’s busy researchers,” said Diku Mandavia, MD, FACEP, FRCPC, chief medical officer and senior vice president, FUJIFILM SonoSite Inc. and FUJIFILM Medical Systems U.S.A., Inc. “Our trusted Vevo technology is already used in hundreds of research laboratories. The new Vevo LAZR-X takes it to the next level, providing the ultimate preclinical imaging experience through a dual tool comprised of state-of-the-art ultra high frequency ultrasound and advanced photoacoustic technology.”

Offering a fusion of anatomical, functional and molecular data, Vevo LAZR-X was designed for non-invasive, real-time, longitudinal studies. The all-in-one imaging platform puts more data at the users’ fingertips and is equipped with an array of software applications that allow researchers to conduct in-depth analysis and rapid quantification to advance research and get published faster.
A portable, customizable system, Vevo LAZR-X pairs Fujifilm VisualSonics’ Vevo 3100 ultrasound system, which provides unparalleled resolution, with the compact LAZR-X cart featuring advanced laser technology for fast, sensitive acquisition along with dual wavelength ranges including signal (680-970 nm) and idler (1200-2000 nm). High-resolution MX linear array transducers can be paired with interchangeable, high-efficiency optical fibers—giving researchers the ability to customize depth, sensitivity and resolution for specific imaging needs. Other features include streamlined data management, an intuitive touchscreen interface, ergonomically-designed transducers, and a unique open imaging environment that allows the researcher to access and manipulate the subject animal during the scanning process.

“At Fujifilm VisualSonics our purpose is to boldly innovate new technologies that help scientists and researchers advance human health. Our new Vevo LAZR-X platform is a great example of this continual innovation. It is designed with flexibility in mind, allowing for application-specific imaging to collect robust data for exceptional translational research,” said Andrew Needles, director of marketing and product management, FUJIFILM VisualSonics, Inc.

Ultrasound Homepage